Literature DB >> 17278119

Prognostic significance of lymph node metastasis and surgical margin status for distal cholangiocarcinoma.

Yoshiaki Murakami1, Kenichiro Uemura, Yasuo Hayashidani, Takeshi Sudo, Yasushi Hashimoto, Hiroki Ohge, Taijiro Sueda.   

Abstract

BACKGROUND AND OBJECTIVES: Prognostic indicators for patients with distal cholangiocarcinoma have not been confirmed because of its rarity. The aim of this study was to identify useful prognostic factors in patients undergoing surgical resection for distal cholangiocarcinoma.
METHODS: Charts of 43 patients with distal cholangiocarcinoma who underwent surgical resection were retrospectively reviewed. Pancreatoduodenectomy was performed in 35 patients, and segmental bile duct resection in 8. Potential clinicopathological prognostic factors were examined by univariate and multivariate survival analysis.
RESULTS: Postoperative complications occurred after surgery in 19 patients (44%), but there was no mortality. Overall survival rates were 72%, 53%, and 44% for 1, 3, and 5 years, respectively (median survival time, 26.0 months). Univariate analysis found that older age, pathological pancreatic invasion, lymph node metastasis, perineural invasion, positive surgical margin, and TNM stages II and III were significant predictors of poor prognosis (P < 0.05). Furthermore, lymph node metastasis and positive surgical margin were found to be significant independent predictors of poor prognosis with a Cox proportional hazards regression model (P < 0.05).
CONCLUSIONS: These results suggest that lymph node metastasis and positive surgical margin as determined by surgical resection might be useful in predicting post-surgical outcome in patients with distal cholangiocarcinoma.

Entities:  

Mesh:

Year:  2007        PMID: 17278119     DOI: 10.1002/jso.20668

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  35 in total

1.  Neither neoadjuvant nor adjuvant therapy increases survival after biliary tract cancer resection with wide negative margins.

Authors:  Evan S Glazer; Ping Liu; Eddie K Abdalla; Jean-Nicolas Vauthey; Steven A Curley
Journal:  J Gastrointest Surg       Date:  2012-07-10       Impact factor: 3.452

2.  Array comparative genomic hybridization identifies novel potential therapeutic targets in cholangiocarcinoma.

Authors:  Siobhan C McKay; Kristian Unger; Stephanos Pericleous; Gordon Stamp; Gerry Thomas; Robert R Hutchins; Duncan R C Spalding
Journal:  HPB (Oxford)       Date:  2011-03-10       Impact factor: 3.647

3.  Prognostic factors in patients with advanced cholangiocarcinoma: role of surgery, chemotherapy and body mass index.

Authors:  Mirna H Farhat; Ali I Shamseddine; Ayman N Tawil; Ghina Berjawi; Charif Sidani; Wael Shamseddeen; Kassem A Barada
Journal:  World J Gastroenterol       Date:  2008-05-28       Impact factor: 5.742

4.  Pancreaticoduodenectomy for distal cholangiocarcinoma: surgical results, prognostic factors, and long-term follow-up.

Authors:  Stefano Andrianello; Salvatore Paiella; Valentina Allegrini; Marco Ramera; Alessandra Pulvirenti; Giuseppe Malleo; Roberto Salvia; Claudio Bassi
Journal:  Langenbecks Arch Surg       Date:  2015-07-02       Impact factor: 3.445

Review 5.  The survival outcome and prognostic factors for distal cholangiocarcinoma following surgical resection: a meta-analysis for the 5-year survival.

Authors:  U F Wellner; YinFeng Shen; T Keck; WenYin Jin; Ze Xu
Journal:  Surg Today       Date:  2016-05-28       Impact factor: 2.549

6.  A case of distal extrahepatic cholangiocarcinoma with two positive resection margins.

Authors:  Wayne A Warner; Wesley Ramcharan; Dave Harnanan; Srikanth Umakanthan; Ravi Maharaj
Journal:  Oncol Lett       Date:  2016-09-22       Impact factor: 2.967

7.  Over 700 Whipples for Pancreaticobiliary Malignancies: Postoperative Morbidity Is an Additional Negative Prognostic Factor for Distal Bile Duct Cancer.

Authors:  Stefano Andrianello; Giovanni Marchegiani; Giuseppe Malleo; Borislav Chavdarov Rusev; Aldo Scarpa; Deborah Bonamini; Laura Maggino; Claudio Bassi; Roberto Salvia
Journal:  J Gastrointest Surg       Date:  2016-11-23       Impact factor: 3.452

8.  Carcinoma of the middle bile duct: is bile duct segmental resection appropriate?

Authors:  Hyung-Geun Lee; Sang-Hoon Lee; Dong-Do Yoo; Kwang-Yeol Paik; Jin-Seok Heo; Seong-Ho Choi; Dong-Wook Choi
Journal:  World J Gastroenterol       Date:  2009-12-21       Impact factor: 5.742

9.  Incidence of port-site metastasis after undergoing robotic surgery for biliary malignancies.

Authors:  Quan-Da Liu; Jun-Zhou Chen; Xiao-Ya Xu; Tao Zhang; Ning-Xin Zhou
Journal:  World J Gastroenterol       Date:  2012-10-28       Impact factor: 5.742

10.  Depth of tumor invasion better predicts prognosis than the current American Joint Committee on Cancer T classification for distal bile duct carcinoma.

Authors:  Seung-Mo Hong; Timothy M Pawlik; Hyungjun Cho; Bhuvnesh Aggarwal; Michael Goggins; Ralph H Hruban; Robert A Anders
Journal:  Surgery       Date:  2009-08       Impact factor: 3.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.